Seminars in Thrombosis and Hemostasis

LinksSchließen

Referenz

CRASH-3 trial collaborators.
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.

Lancet 2019;
394 (10210): 1713-1723

Bibliographische Angaben herunterladen

Aufrufen in: